TABLE 1.
Characteristics of Studies Involving Prevalence of NAFLD in IBD Patients
| Study, Year (Reference) | Country | Region | Study Design | Abstract vs Article | Total IBD Patients, n | Men/ Women, n/n | Mean Age, y | Mean BMI, n | IBD Patients with Hepatic Steatosis, n |
|---|---|---|---|---|---|---|---|---|---|
| Andrade et al, 201619 | Portugal | Europe | R, Chart Review, S | Abstract | 54 | 35/19 | 43 +/- 12 | NR | 13 |
| Balaban et al, 201720 | Romania | Europe | P, Observational, S | Abstract | 36 | 17/19 | 43 +/- 13 | 23.5 | 11 |
| Balaban et al, 201721 | Romania | Europe | P, Observational, S | Abstract | 62 | 31/31 | 45 +/- 15 | 24.2 | 23 |
| Bessisow et al, 201622 | Canada | North America | R, Longtiduinal, S | Article | 321 | 151/170 | Median: 33.7 (25.1–46.9) | Median: 22.9 (20.9–24.7) | 108 |
| Bosch et al, 201723 | United States | North America | R, Chart Review, S | Article | 49 | 25/24 | 47 | 27.6 | 29 |
| Chhina et al, 201424 | United States | North America | R, Chart Review, S | Abstract | 1304 | NR/NR | NR | NR | 126 |
| DiGirolamo et al, 201325 | Italy | Europe | R, Chart Review, S | Abstract | 788 | NR/NR | NR | NR | 128 |
| Donati et al, 201626 | France | Europe | P, Case Series, S | Abstract | 114 | NR/NR | NR | NR | 0 |
| Dundulis et al, 201427 | United States | North America | R, Case Control, S | Abstract | 70 | 31/39 | 38.6 +/- 14.9 | 26.6 +/- 6.9 | 29 |
| Erzin et al, 201528 | Turkey | Europe | R, Cross Sectional, S | Abstract | 276 | 132/144 | 44.39 +/- 14.14 | 24.08 | 100 |
| Kang et al, 201829 | South Korea | Asia | R, Case Control, S | Abstract | 720 | NR/NR | NR | NR | 5 |
| Likhitsup et al, 201730 | United States | North America | P, Cross Sectional, S | Abstract | 80 | 44/36 | 42.4 +/- 15 | 26 +/- 5.7 | 43 |
| Magnes et al, 201831 | Canada | North America | R, Chart Reivew, S | Abstract | 35 | NR/NR | NR | NR | 26 |
| Mancina et al, 201632 | Italy | Europe | R, Cohort, S | Article | 106 | 97/61 | 45+/- 13 | 26 +/- 4 | 75 |
| Mariabeatrice et al, 201833 | Italy | Europe | P, Case Series, S | Article | 465 | 241/224 | 46.2 +/- 15.6 | 24.7 +/- 5.3 | 130 |
| McGowan et al, 201834 | United States | North America | R, Case Series, S | Article | 7 | 2/5 | 35.4 | 32.4 | 7 |
| Mehrotra et al, 201335 | India | Asia | P, Case Series, S | Abstract | 20 | 14/6 | 42 +/- 4 | NR | 3 |
| Mehrotra et al, 201836 | India | Asia | P, Case Control, S | Abstract | 128 | NR/NR | NR | NR | 23 |
| Palumbo et al, 201837 | Canada | North America | P, Case Series, S | Abstract | 326 | 159/167 | 42.8 +/- 15.5 | NR | 129 |
| Peixoto et al, 201738 | Portugal | Europe | P, Cross Sectional, S | Abstract | 62 | 27/35 | 37.5 +/- 11.3 | NR | 23 |
| Quang Le et al, 201439 | United States | North America | R, Longitudinal, S | Abstract | 232 | 116/116 | 33.8 | NR | 60 |
| Restellini et al, 201740 | Canada | North America | P, Case Series, S | Abstract | 349 | 170/179 | 42.5 +/- 15.2 | NR | 135 |
| Sagami et al, 201741 | Japan | Asia | R, Cohort, S | Article | 303 | 226/77 | 36.9 +/- 12.2 | 20.21 | 66 |
| Schroder et al, 201542 | Germany | Europe | R, Chart Review, M | Article | 259 | 101/158 | 37.2 +/- 0.8 | 24.3 +/- 0.3 | 73 |
| Simon et al, 201843 | United States | North America | P, Case Series, S | Abstract | 462 | NR/NR | NR | NR | 240 |
| Sourianarayanane et al, 201313 | United States | North America | R, Nested Case Control, S | Article | 928 | w/ NAFLD 31/45; w/o NAFLD 61/80 | w/NAFLD 46 +/13.3; w/o NAFLD 42 +/-14.1 | w/ NAFLD 30.4 +/- 8.5; w/o NAFLD 27.0 +/- 6.1 | 76 |
| Steenhuis et al, 201844 | Netherlands | Europe | P, Case Series, S | Abstract | 84 | NR/NR | 44.2 | 24.94 | 35 |
Abbreviations: R, retrospective; P, prospective; S, single center; M, multi-center; NR, not available